SECURITIES AND EXCHANGE COMMISSION

                      Washington, D.C. 20549

                           Schedule 13G


            Under the Securities Exchange Act of 1934
                        (Amendment No. )*


                    ACADIA PHARMACEUTICALS INC
             _______________________________________
                         (Name of Issuer)


                          Common Stock
             _______________________________________
                  (Title of Class of Securities)


                            004225108
             _______________________________________
                          (CUSIP Number)


Check the following box if a fee is being paid with this statement.
(A fee is not required only if the filing person: (1) has a
previous statement on file reporting beneficial ownership of more
than five percent of the class of securities described in Item 1;
and (2) has filed no amendment subsequent thereto reporting
beneficial ownership of five percent or less of such class.)  (See
Rule 13d-7.)

*The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided
in a prior cover page.

The information required in the remainder of this cover page shall
not be deemed to be "filed" for the purpose of Section 18 of the
Securities Exchange Act of 1934 ("Act") or otherwise subject to the
liabilities of that section of the Act but shall be subject to all
other provisions of the Act (however, see the Notes).

                 (Continued on following page(s))

                        Page 1 of 8 Pages






CUSIP NO. 004225108              13G              Page 2 of 8 Pages

1   Name of Reporting Person
    S.S. or I.R.S. Identification No. of Above Person

    T. ROWE PRICE ASSOCIATES, INC.
    52-0556948

2   Check the Appropriate Box if a Member of a Group*
                                                        (a) ____
    NOT APPLICABLE                                     (b) ____

3   SEC Use Only
    ______________________________

4   Citizenship or Place of Organization

    MARYLAND

Number of       5  Sole Voting Power
                **
Shares             36,000

Beneficially    6  Shared Voting Power
                **
Owned By Each      NONE

Reporting       7  Sole Dispositive Power
                **
Person             1,482,621

With            8  Shared Dispositive Power

                   NONE

9   Aggregate Amount Beneficially Owned by Each Reporting Person

    1,482,621

10  Check Box if the Aggregate Amount in Row (9) Excludes Certain
    Shares*

    NOT APPLICABLE

11  Percent of Class Represented by Amount in Row 9

    6.2%

12  Type of Reporting Person*

    IA
               *SEE INSTRUCTION BEFORE FILLING OUT!
         **Any shares reported in Items 5 and 6 are also
                       reported in Item 7.
CUSIP NO. 004225108              13G              Page 3 of 8 Pages

1   Name of Reporting Person
    S.S. or I.R.S. Identification No. of Above Person

    T. ROWE PRICE NEW HORIZONS FUND, INC.
    52-0791372

2   Check the Appropriate Box if a Member of a Group*
                                                        (a) ____
    NOT APPLICABLE                                     (b) ____

3   SEC Use Only

    ______________________________

4   Citizenship or Place of Organization

    MARYLAND

Number of       5  Sole Voting Power
                **
Shares             1,442,221

Beneficially    6  Shared Voting Power
                **
Owned By Each      NONE

Reporting       7  Sole Dispositive Power
                **
Person             NONE

With            8  Shared Dispositive Power

                   NONE

9   Aggregate Amount Beneficially Owned by Each Reporting Person

    1,442,221

10  Check Box if the Aggregate Amount in Row (9) Excludes Certain
    Shares*

    NOT APPLICABLE

11  Percent of Class Represented by Amount in Row 9

    6.1%

12  Type of Reporting Person*

    IV

               *SEE INSTRUCTION BEFORE FILLING OUT!
**The aggregate amount reported on this page is also included in
the aggregate amount reported by T. Rowe Price Associates, Inc. on
page 2 of this Schedule 13G.

SCHEDULE 13G
PAGE 4 OF 8

Item 1(a)  Name of Issuer:

           Reference is made to page 1 of this Schedule 13G

Item 1(b)  Address of Issuer's Principal Executive Offices:

           3911 Sorrento Valley Blvd, San Diego, CA  92121


Item 2(a)  Name of Person(s) Filing:

           (1)  T. Rowe Price Associates, Inc. ("Price Associates")

           (2) T. Rowe Price New Horizons Fund, Inc.

  X        Attached as Exhibit A is a copy of an agreement between
           the Persons Filing (as specified hereinabove) that this
           Schedule 13G is being filed on behalf of each of them.

Item 2(b)  Address of Principal Business Office:

           100 E. Pratt Street, Baltimore, Maryland 21202

Item 2(c)  Citizenship or Place of Organization:

           (1) Maryland

           (2) Maryland

Item 2(d)  Title of Class of Securities:

           Reference is made to page 1 of this Schedule 13G

Item 2(e)  CUSIP Number: 004225108


Item 3     The person filing this Schedule 13G is an:

  X        Investment Adviser registered under Section 203 of the
           Investment Advisers Act of 1940

  X        Investment Company registered under Section 8 of the
           Investment Company Act of 1940


Item 4     Reference is made to Items 5-11 on page 2 of this
           Schedule 13G.
CUSIP 004225108
PAGE  5  OF 8

Item 4     Ownership                           Deemed
                                           Outstanding
                                               And
                                           Beneficially
                              Units       Owned Directly
                              Deemed        Subject to
                           Beneficially     Warrants &
                              Owned         Conversion
                             Directly       Privileges    Total
                           ____________   ______________ _______

(1)  WITH RESPECT TO
     PRICE ASSOCIATES
     (includes shares
     reported in
     (2) below):

     (a)Amount
         Beneficially
         Owned . . . . . .    1,352,621     130,000     1,482,621

     (b)Percent of
         Class . . . . . . . . . . . . . . . . . . . . . .  6.2%

     (c)Number of
         units as
         to which
         such
         person has: . . .

        (i)  *sole power
             to vote or
             to direct
             the vote . . .     36,000          -0-        36,000

       (ii)  *shared power
             to vote or
             to direct
             the vote . . .      -0-            -0-          -0-

      (iii)  *sole power
             to dispose or
             to direct the
             disposition
             of . . . . .      1,352,621        130,000   1,482,621

       (iv)  *shared power
             to dispose or
             to direct the
             disposition
             of . . . . .        -0-            -0-          -0-
                                               Page  6  of  8

                                               Cusip No. 004225108

(2)  WITH RESPECT TO
     T. Rowe Price New Horizons Fund, Inc.
     (if this is a
     joint filing):

     (a)Amount
         Beneficially
         Owned . . . . . .    1,312,221      130,000     1,442,221

     (b)Percent of
         Class . . . . . . . . . . . . . . . . . . . . . .   6.1%

     (c)Number of
         units as
         to which
         such person
         has . . . . . . .

        (i)  *sole power to
             vote or to
             direct the
             vote . . . .      1,312,221    130,000      1,442,221

       (ii)  *shared power
             to vote or
             to direct
             the vote . . .       -0-           -0-          -0-

      (iii)  *sole power
             to dispose or
             to direct the
             disposition
             of . . . . .         -0-           -0-          -0-

       (iv)  *shared power
             to dispose or
             to direct the
             disposition
             of . . . . .         -0-           -0-          -0-

*Units reported in subcategories (i) and (ii) are also included in
subcategory (iii) or (iv).
SCHEDULE 13G
PAGE 7 OF 8

Item 5 Ownership of Five Percent or Less of a Class.

  X    Not Applicable.

_____  This statement is being filed to report the fact that, as
       of the date of this report, the reporting person(s) has
       (have) ceased to be the beneficial owner of more than five
       percent of the class of securities.

Item 6 Ownership of More than Five Percent on Behalf of Another
       Person

       (1) Price Associates does not serve as custodian of the
           assets of any of its clients; accordingly, in each
           instance only the client or the client's custodian or
           trustee bank has the right to receive dividends paid
           with respect to, and proceeds from the sale of, such
           securities.

           The ultimate power to direct the receipt of dividends
           paid with respect to, and the proceeds from the sale
           of, such securities, is vested in the individual and
           institutional clients which Price Associates serves as
           investment adviser.  Any and all discretionary
           authority which has been delegated to Price Associates
           may be revoked in whole or in part at any time.

           Except as may be indicated if this is a joint filing
           with one of the registered investment companies
           sponsored by Price Associates which it also serves as
           investment adviser ("T. Rowe Price Funds"), not more
           than 5% of the class of such securities is owned by any
           one client subject to the investment advice of Price
           Associates.

       (2) With respect to securities owned by any one of the T.
           Rowe Price Funds, only State Street Bank and Trust
           Company, as custodian for each of such Funds, has the
           right to receive dividends paid with respect to, and
           proceeds from the sale of, such securities.  No other
           person is known to have such right, except that the
           shareholders of each such Fund participate
           proportionately in any dividends and distributions so
           paid.

Item 7 Identification and Classification of the Subsidiary Which
       Acquired the Security Being Reported on By the Parent
       Holding Company.

       Not Applicable.

Item 8 Identification and Classification of Members of the Group.

       Not Applicable.
SCHEDULE 13G
PAGE 8 OF 8

Item 9    Notice of Dissolution of Group.

          Not Applicable.

Item 10   Certification.

          By signing below I (we) certify that, to the best of my
          (our) knowledge and belief, the securities referred to
          above were acquired in the ordinary course of business
          and were not acquired for the purpose of and do not have
          the effect of changing or influencing the control of the
          issuer of such securities and were not acquired in
          connection with or as a participant in any transaction
          having such purpose or effect.  T. Rowe Price
          Associates, Inc. hereby declares and affirms that the
          filing of Schedule 13G shall not be construed as an
          admission that Price Associates is the beneficial owner
          of the securities referred to, which beneficial
          ownership is expressly denied.

                            Signature.

          After reasonable inquiry and to the best of my (our)
          knowledge and belief, I (we) certify that the
          information set forth in this statement is true,
          complete and correct.

Dated:  February 14, 2006           Dated: February 14, 2006

T. ROWE PRICE NEW HORIZONS          T. ROWE PRICE ASSOCIATES, INC.
         FUND, INC.



By:  /s/ Joseph A. Carrier          By: /s/ Henry H. Hopkins
     Joseph A. Carrier,                 Henry H. Hopkins,
     Treasurer                          Vice President


Note:     This Schedule 13G, including all exhibits, must be filed
          with the Securities and Exchange Commission, and a copy
          hereof must be sent to the issuer by registered or
          certified mail not later than February 14th following
          the calendar year covered by the statement or within the
          time specified in Rule 13d-1(b)(2), if applicable.

12/31/2005
                                                   EXHIBIT A


                            AGREEMENT

                   JOINT FILING OF SCHEDULE 13G


      T. Rowe Price Associates, Inc. (an investment adviser
registered under the Investment Advisers Act of 1940), T. Rowe
Price New Horizons Fund, Inc., a Maryland corporation, hereby agree
to file jointly the statement on Schedule 13G to which this
Agreement is attached, and any amendments thereto which may be
deemed necessary, pursuant to Regulation 13D-G under the Securities
Exchange Act of 1934.

      It is understood and agreed that each of the parties hereto
is responsible for the timely filing of such statement and any
amendments thereto, and for the completeness and accuracy of the
information concerning such party contained therein, but such party
is not responsible for the completeness or accuracy of information
concerning the other party unless such party knows or has reason to
believe that such information is inaccurate.

      It is understood and agreed that a copy of this Agreement
shall be attached as an exhibit to the statement on Schedule 13G,
and any amendments hereto, filed on behalf of each of the parties
hereto.


Dated:  February 14, 2006           Dated: February 14, 2006


T. ROWE PRICE NEW HORIZONS          T. ROWE PRICE ASSOCIATES, INC.
         FUND, INC.



By:  /s/ Joseph A. Carrier          By: /s/ Henry H. Hopkins
     Joseph A. Carrier,                 Henry H. Hopkins,
     Treasurer                          Vice President